Merck will spend about $11.5 billion to buy Acceleron Pharma and its potential treatment for high blood pressure in vessels that connect the lungs and heart.
Merck will pay $180 per share in cash for Acceleron, the Kenilworth, New Jersey, company said Thursday.
ALBANY, N.Y. (AP) — New York's governor announced Friday the state will open up vaccine eligibility by Feb...
ADVERTISEMENT
Doctors have long known that Black people suffer disproportionately.
Before the renewed cries of “Black Lives Matter,” they knew racism has very real, physical effects...